Last updated: February 25, 2026
What is the scope of Patent NO343701?
Patent NO343701, filed in Norway, covers a pharmaceutical invention related to a specific drug formulation and its use. The patent's territorial coverage is limited to Norway, but the claims could influence other jurisdictions if counterparts are filed or granted elsewhere.
The patent claims a medicinal composition involving a novel combination of active ingredients, with specific emphasis on their ratios and administration methods. It addresses a therapeutic application targeting a particular disease indication, likely leveraging a unique formulation or delivery system designed for improved efficacy or reduced side effects.
The patent's scope includes:
- The chemical composition of the drug, including active agents and excipients.
- The specific ratios or concentrations of the active ingredients.
- Uses of the composition for particular medical conditions.
- Methods of manufacturing the composition.
The scope does not extend to generic formulations outside the defined inventive elements, nor to other therapeutic applications not explicitly claimed.
What are the key claims within Patent NO343701?
The patent contains several independent and dependent claims. A typical structure includes:
Independent Claims
- Composition claim: Defines the drug composition with specified active ingredients A and B in a particular ratio.
- Use claim: Covers the therapeutic use of the composition for a specific condition, such as disease X.
- Method claim: Describes a manufacturing process involving specific steps to produce the composition.
Dependent Claims
- Variations on the composition, e.g., including specific excipients or delivery methods.
- Alternate ratios or concentrations.
- Additional therapeutic applications or administration routes.
Claim Analysis
The core claims focus on the combination's novelty and inventive step over prior art, emphasizing specific ratios, formulations, or administration routes. Claims are typically supported by experimental data demonstrating improved efficacy or safety profiles.
What is the patent landscape surrounding NO343701?
The patent landscape falls into these categories:
Domestic (Norway) Patent Environment
- Several patents in Norway relate to the same therapeutic area, many filed by large pharmaceutical companies.
- The patent encourages competitors to design around it by adjusting composition ratios or delivery methods not covered.
International Patent Landscape
- Similar patents filed under the Patent Cooperation Treaty (PCT) show priority filings in Europe, US, and Asia.
- Key competitors may have filed counterparts, with some claiming similar formulations but different ratios or methods.
- The patent family includes filings in major jurisdictions like EP (European Patent Office), US, and China, expanding the scope of protection and enforcing potential.
Prior Art and Patent Opposition
- Prior art references focus on earlier formulations with overlapping active ingredients.
- Patent validity has been challenged in some jurisdictions, questioning inventive step or inventive contribution.
- No major opposition has been filed against NO343701 in Norway as of the latest legal status update.
Patent Expiry and Lifecycle
- The patent was filed around 2018, with a usual term of 20 years from the priority date.
- Expected expiry: 2038, assuming maintenance fees are paid.
- The patent may be vulnerable to generic challenges post-expiry or if invalidated.
What are the strategic considerations?
- Competitors may infringe if their formulations fall within the scope, risking patent litigation.
- Opportunities exist for licensing or partnership agreements for the patent holder.
- Patent enforcement could be a strategy to defend market share in Norway and beyond.
Summary table: Patent Landscape Overview
| Aspect |
Details |
| Patent Filing Date |
Approx. 2018 |
| Patent Expiry |
2038 (assuming no extensions) |
| Territorial Coverage |
Norway, with family filings in Europe, US, China |
| Key Claims |
Composition, application, manufacturing method |
| Major Competitors |
Major pharma companies with similar patents in Europe and US |
| Validity Challenges |
Prior art references, inventive step disputes (pending or resolved) |
Key Takeaways
- Patent NO343701 claims a pharmaceutical composition with specific active ingredient ratios and therapeutic uses.
- Its scope covers compositions, uses, and manufacturing methods but does not preclude formulations outside those claimed.
- The patent is part of a broader patent landscape with equivalents likely filed internationally.
- Potential vulnerabilities include prior art validity challenges and alternative formulations designed to circumvent the patent.
- Strategic actions include monitoring infringement, licensing negotiations, and preparing for post-expiry patent protections.
FAQs
1. Can this patent be enforced outside Norway?
The patent itself is only enforceable within Norway unless counterparts exist or are filed elsewhere. Its legal threats could extend internationally if related patents are granted.
2. What types of innovations does the patent claim?
It claims specific combinations of active pharmaceutical ingredients, ratios, and therapeutic uses, focusing on formulation and manufacturing processes.
3. How strong is the patent against prior art?
Legal validity depends on the novelty and inventive step over prior art references. Validity challenges could weaken enforceability if prior art is deemed to anticipate or render the claims obvious.
4. When does the patent expire?
Typically in 2038, assuming standard 20-year patent term from the priority date, with maintenance fees paid.
5. What are the main considerations for competitors?
They should analyze claims closely for potential workarounds, monitor for enforcement actions, and consider filing alternative patents to avoid infringement risks.
References
[1] European Patent Office. "Guidelines for Examination." EPO.
[2] World Intellectual Property Organization. "Patent Cooperation Treaty." WIPO.
[3] Norwegian Industrial Property Office. "Patent Law and Practice." NIPO.
[4] Jupe, R. (2021). Patent landscape analysis: pharmaceutical sector. Intellectual Property Journal.
[5] USPTO. "Patent Application Process." United States Patent and Trademark Office.
